Vident Investment Advisory’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
CS
B
Vident Investment Advisory's CLLS Position: Q2 2022 in Review
Vident Investment Advisory sold out of Cellectis (CLLS) in Q2 2022, closing a stake of 17,696 shares — an estimated $80K sold.
Vident Investment Advisory first reported a position in CLLS in Q4 2015 and held it in 23 quarters. The position peaked at $2.28M in Q2 2018. 45 funds tracked by Wall St. Rank hold CLLS as of Q2 2022.
- Vident Investment Advisory reported no remaining Cellectis position as of Q2 2022 after selling out during the quarter.
- Vident Investment Advisory sold 17,696 Cellectis shares in Q2 2022, an estimated $80K.
- Vident Investment Advisory first reported a position in Cellectis in Q4 2015 and held it in 23 quarters.
- Vident Investment Advisory's Cellectis position peaked at $2.28M in Q2 2018.
- 45 funds tracked by Wall St. Rank held Cellectis as of Q2 2022.
Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.